Nucala 100 mg/mL
mepolizumab · INJECTION, SOLUTION · GlaxoSmithKline LLC
No Recall History
Plain English
Nucala is a injection, solution containing mepolizumab at 100 mg/mL, taken subcutaneous. Manufactured by GlaxoSmithKline LLC.
Key Facts
- Brand Name
- Nucala
- Generic Name
- mepolizumab
- NDC Code (Product)
0173-0892- Manufacturer
- GlaxoSmithKline LLC
- Strength
- 100 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761122
- Drug Class
- Interleukin-5 Antagonist [EPC]
- Marketing Start
- 06/06/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is Nucala used for?
Nucala contains mepolizumab. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Nucala a controlled substance?
Nucala is not classified as a controlled substance by the DEA.
What is the generic name for Nucala?
The generic name for Nucala is mepolizumab. There are no other listed brand versions of mepolizumab.
What is the NDC code for Nucala 100 mg/mL?
The NDC (National Drug Code) for Nucala 100 mg/mL is 0173-0892, listed by GlaxoSmithKline LLC.
Other Nucala Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)